The neffyinSchools program from ARS Pharma will provide eligible public and private K-12 schools in the United States with ...
Four new SPMS patients not eligible for a Tiziana Life Sciences trial were dosed with foralumab nasal spray in an expanded access program.
The Prescription Drug User Fee Act (PDUFA) date refers to the deadline set by the US Food and Drug Administration (FDA) for reviewing a New Drug Application (NDA) or Biologics License Application (BLA ...
Compared with placebo, zavegepant nasal spray yielded sustained relief of acute pain and function in migraine.
Milestone Pharmaceuticals (MIST) announced that it has received Notice of Allowance from the United States Patent and Trademark Office, or ...
Extends US patent protection until 2042MONTREAL and CHARLOTTE, N.C., Feb. 19, 2025 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (Nasdaq: MIST) a biopharmaceutical company focused on the ...
Seventy-eight-year-old Joe Walsh, of Quincy, is in a unique position. He is the first patient to have permission from the U.S. Food and Drug Administration to try a nasal spray for moderate ...
2d
Medpage Today on MSNNoted Neuroscientist Dies; Nasal Spray for Alzheimer's Disease; Benign MSCognitive neuroscientist Eleanor Maguire, PhD, whose studies of London taxi drivers' brains helped transform memory research, ...
Nasal vaccine devices have the potential to offer more convenient and more effective protection against a variety of viruses.
STATEN ISLAND, N.Y. — The U.S. Food and Drug Administration (FDA) has announced a recall of 89,312 bottles of a popular nasal ...
Quincy man becomes first Alzheimer’s patient to try nasal spray drug: ‘I’m hoping like heck’
Retired electrician Joe Walsh in December became the first Alzheimer’s patient to try a nasal spray used to treat other ...
There’s another recall to be aware of right now, and it involves nose spray. NeilMed Pharmaceuticals Inc., the manufacturer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results